Schedule 13G ownership disclosure

ACURA PHARMACEUTICALS, INC

Security class unavailable · CUSIP: 00509L703

Event date: 2015-07-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,661,795
Percent of class
7.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-15-000065
Form type
SC 13G
Filer
ACURA PHARMACEUTICALS, INC
CIK
CIK 786947
Filed
Jul 09, 2015
Reporting period
Jul 01, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub